| Sandoz Pharmaceuticals AG - Rivastigmin Patch Sandoz eco 13,3 mg/24 h (23,1 mg), transdermale Pflaster | | 70340 | | 03 | | Rivastigmin Patch Sandoz eco 13,3 mg/24 h (23,1 mg) | | transdermale Pflaster | | N06DA03 | | Rivastigmine | | 16.04.2026 | | |
| | Composition | | rivastigminum 23.1 mg, acidi acrylici et acrylates polymerisatum, ammonio methacrylatis copolymerum B, acrylates polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Schwarz): ad praeparationem pro 13.5 cm² cum liberatione 13.3 mg/24h. | | Packungsbestandteile | | Transdermal patch | | | | Active Agent | Dose |
|---|
| Rivastigmine | 23.1 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Acrylici | | | | Acrylates Polymerisatum | | | | Ammonio Methacrylatis Copolymerum B | | | | Cum Liberatione | 13.3mg / 24h | | | Drucktinte (Schwarz): ad Praeparationem | 13.5 cm | | | Poly(Ethylenis Terephthalas) | | Trägermaterial |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 30 | | | B | | Yes | | 005 | 60 | | | B | | Yes |
|
|
